SCHEMBL16329947

O=S(=O)(O)OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC[C@@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](CO[C@@H]3O[C@H](CO[C@@H]4O[C@H](COS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]4OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]2OS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O

nearest known ligand 0.48

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	FGF1	P05230	9/20	0.48

▸	FGF2	P09038	7/20	0.48

▸	SERPINC1	P01008	1/20	0.41

▸	HPSE	Q9Y251	15/20	0.37

▸	VEGFA	P15692	5/20	0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL16329960	0.98	FGF1 (0.47)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL1787297	0.98	FGF1 (0.50)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL12798122	0.98	FGF1 (0.50)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL14368574	0.95	FGF1 (0.48)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL1788586	0.95	FGF1 (0.48)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL14368408	0.95	FGF1 (0.48)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL1785565	0.95	FGF1 (0.48)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL16329942	0.95	FGF1 (0.48)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL1785134	0.95	FGF1 (0.48)	FGF1FGF2SERPINC1HPSEVEGFA
SCHEMBL14345974	0.93	FGF1 (0.43)	FGF1FGF2SERPINC1HPSEVEGFA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-8987216-B2	Polysulfated glycosides and salts thereof	Teva Hungary Pharmaceutical Marketing Private Limited Company (HU)	2015-03-24	—	—	US	disclosed
US-20110118198-A1	POLYSULFATED GLYCOSIDES AND SALTS THEREOF	IVAX DRUG RESEARCH INSTITUTE LTD. (HU)	2011-05-19	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20110118198-A1	POLYSULFATED GLYCOSIDES AND SALTS THEREOF	CFTR, AREG, STS	FGF1 1447/4885FGF2 919/4885SERPINC1 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.